Pharma companies moved fast in 2020 to tackle Covid-19 and to address longstanding issues of racial equity, the CEOS of BD and Sanofi said in a session at the J.P. Morgan Healthcare Conference. The challenge lies in keeping the momentum going in 2021.
In a wide-ranging discussion at J.P. Morgan's Annual Healthcare Conference, former CMS Administrator Andy Slavitt talked about the future of the ACA, telehealth and Medicare Advantage with a Democrat-led House, Senate and presidency.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In an increasingly crowded landscape, digital health startups must figure out what sets them apart. Three startup leaders shared what differentiates their companies from the competition at this year's J.P. Morgan Healthcare Conference.
Moderna's leadership team dodged questions about their assessment of the largely slow and dysfunctional vaccine rollout focusing instead of telling the story of the science behind a decade-old biopharma company whose first commercial product is making history.
Ugur Sahin presented a sweeping vision of the company's goal to become a next-generation immunotherapy company leveraging the messenger RNA platform technology that has won it acclaim and financial returns during the Covid-19 pandemic.
A subsidiary of Northwell Health is partnering with Whole Foods Market to offer its New York-based employees access to seven primary care locations. The supermarket chain's employees will not be subject to a deductible or co-pay.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.